VANCOUVER, BC / ACCESS Newswire / March 21, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce the execution of a formal exit agreement ...
11d
AIML Appoints Dr. Paul Dorian as Medical Innovation Architect and Head of the Medical Advisory Board
Dr. Dorian succeeds Peter Kendall, who previously served as Chair of the Medical Advisory Board. This leadership transition comes as AIML enters a phase of advanced clinical validation, regulatory ...
These patents strengthen AIML's position in the growing field of AI-assisted cardiology by protecting both the algorithmic foundations and the applied deployment stack of its technology. The dynamic ...
VANCOUVER, BC / ACCESS Newswire / September 4, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce that it intends to complete a ...
VANCOUVER, BC / ACCESS Newswire / April 25, 2025 / AI/ML INNOVATIONS INC. ("AIML" OR THE "COMPANY") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) announces that Tim Daniels has stepped down from his position on ...
VANCOUVER, BC / ACCESS Newswire / August 8, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB: 42FB) is pleased to confirm it has closed its previously announced ...
VANCOUVER, BC / ACCESS Newswire / April 15, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce that Company completed its previously ...
On October 10, 2024, AIML reported an impairment loss of $1,510,668, following an internal assessment of its investment in T2H. While T2H had achieved modest growth, AIML determined that the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results